Neurocrine Biosciences | Nakit Ve Eşdeğer

Cash And Equivalent Değişiklik Tarih
AbbVie USD 13.29B 4.53B 2023-09
Acadia Pharmaceuticals USD 188.66M 90.46M 2023-12
Agios Pharmaceuticals USD 88.2M 23.87M 2023-12
ALKERMES USD 647.71M 18.08M 2023-09
Alnylam Pharmaceuticals USD 812.69M 220.34M 2023-12
Amgen USD 10.94B 23.8B 2023-12
Cytokinetics USD 113.02M 13.33M 2023-12
Dynavax Technologies USD 150.28M 4.23M 2023-12
Exelixis USD 396.86M 67.62M 2023-09
Gilead Sciences USD 8.43B 2.72B 2023-12
Halozyme Therapeutics USD 118.37M 155.86M 2023-12
Incyte USD 3.21B 13.85M 2023-12
Intra Cellular Therapies USD 147.77M 48.36M 2023-12
Ionis Pharmaceuticals USD 399.27M 47.21M 2023-12
Neurocrine Biosciences USD 293.7M 133.5M 2023-09
Pfizer USD 3.15B 516M 2023-09
Regeneron Pharmaceuticals USD 16.24B 14.09B 2023-12
Repligen USD 751.32M 120.54M 2023-12
Sarepta Therapeutics USD 541.93M 310M 2023-09
Teva Pharmaceutical Industries USD 2.25B 420M 2023-09
Ultragenyx Pharmaceutical USD 777.11M 704.54M 2023-12
Vertex Pharmaceuticals USD 11.11B 959.1M 2023-09



Neurocrine Biosciences Nakit Ve Eşdeğer - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Apr 2024.